These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6286267)

  • 1. [Beta lactamase inhibitors, a new start of antibiotic therapy].
    Wundt W; Baumgärtner M
    Dtsch Med Wochenschr; 1982 Aug; 107(34):1285-9. PubMed ID: 6286267
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M; Alarcón MA; González H; Sánchez R
    Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of beta-lactamase inhibitors.
    Jackson D
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of beta-lactamase inhibitors on urinary tract infections].
    Ohkawa M
    Nihon Rinsho; 1986 Dec; 44(12):2573-7. PubMed ID: 3029463
    [No Abstract]   [Full Text] [Related]  

  • 7. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F; Williams J; Yamabe S
    Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
    Yamabe S; Adachi K; Watanabe M; Ueda S
    Chemioterapia; 1987 Oct; 6(5):337-40. PubMed ID: 2827899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties of beta-lactamase inhibitors.
    de la Pena A; Derendorf H
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):63-75. PubMed ID: 10082170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming enzymatic resistance in bacteria: impact on future therapy.
    Labia R; Barthélémy M; Péduzzi J; Morand A; Tiwari K; Kazmierczak A
    J Int Med Res; 1990; 18 Suppl 4():48D-57D. PubMed ID: 2282969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of the New Delhi-Metallolactamase].
    Holzgrabe U
    Pharm Unserer Zeit; 2012 Jul; 41(4):270. PubMed ID: 22763993
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
    Li JT; Moosdeen F; Williams JD
    J Antimicrob Chemother; 1982 Apr; 9(4):287-96. PubMed ID: 6282800
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer β-lactam and β-lactamase inhibitor combinations available in India: consensus and controversies.
    Veeraraghavan B
    Indian J Med Microbiol; 2011; 29(3):315-6. PubMed ID: 21860121
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic studies of the urinary excretion of clavulanic acid in man.
    Haginaka J; Nakagawa T; Hoshino T; Yamaoka K; Uno T
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3342-9. PubMed ID: 7337933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.